25 related articles for article (PubMed ID: 38772386)
1. Feasibility and acceptability of collecting dried blood spots (DBS) from children after vaccination during supplementary immunization activities to estimate measles and rubella seroprevalence.
Carcelen AC; Prosperi C; Hamahuwa M; Kapungu K; Chongwe G; Mwansa FD; Ndubani P; Simulundu E; Bwalya IC; Matakala KH; Musukwa G; Mutale I; Betha E; Chaavwa N; Kampamba L; Matoba J; Munachoonga P; Mufwambi W; Situtu K; Thuma PE; Sakala C; Kayeye P; Truelove SA; Winter AK; Ferrari MJ; Moss WJ; Mutembo S
PLOS Glob Public Health; 2024; 4(6):e0002985. PubMed ID: 38941295
[TBL] [Abstract][Full Text] [Related]
2. Impact of measles supplementary immunisation activities on utilisation of maternal and child health services in low-income and middle-income countries.
Postolovska I; Helleringer S; Kruk ME; Verguet S
BMJ Glob Health; 2018; 3(3):e000466. PubMed ID: 29755760
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Scope and Bias of Population-Level Measles Serosurveys: A Systematized Review and Bias Assessment.
Sbarra AN; Cutts FT; Fu H; Poudyal I; Rhoda DA; Mosser JF; Jit M
Vaccines (Basel); 2024 May; 12(6):. PubMed ID: 38932314
[TBL] [Abstract][Full Text] [Related]
4. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
[TBL] [Abstract][Full Text] [Related]
5. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
Murhekar MV; Gupta N; Hasan AZ; Kumar MS; Kumar VS; Prosperi C; Sapkal GN; Thangaraj JWV; Kaduskar O; Bhatt V; Deshpande GR; Thankappan UP; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma S; Sarmah NP; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Shrivastava AK; Chonker SK; Tilekar B; Tandale BV; Ahmad M; Sangal L; Winter A; Mehendale SM; Moss WJ; Hayford K
Lancet Glob Health; 2022 Nov; 10(11):e1655-e1664. PubMed ID: 36240831
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin.
Kaucley L; Levy P
Cost Eff Resour Alloc; 2015; 13():14. PubMed ID: 26300696
[TBL] [Abstract][Full Text] [Related]
8. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
Portnoy A; Jit M; Helleringer S; Verguet S
Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
[TBL] [Abstract][Full Text] [Related]
9. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
Mak J; Patenaude BN; Mutembo S; Pilewskie ME; Winter AK; Moss WJ; Carcelen AC
Am J Trop Med Hyg; 2024 May; ():. PubMed ID: 38772386
[TBL] [Abstract][Full Text] [Related]
10. A review of measles supplementary immunization activities and the implications for Pacific Island countries and territories.
Clements CJ; Soakai TS; Sadr-Azodi N
Expert Rev Vaccines; 2017 Feb; 16(2):161-174. PubMed ID: 27690704
[TBL] [Abstract][Full Text] [Related]
11. A review of measles control in Kenya, with focus on recent innovations.
Manakongtreecheep K; Davis R
Pan Afr Med J; 2017; 27(Suppl 3):15. PubMed ID: 29296150
[TBL] [Abstract][Full Text] [Related]
12. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.
Fields R; Dabbagh A; Jain M; Sagar KS
Vaccine; 2013 Apr; 31 Suppl 2():B115-21. PubMed ID: 23598472
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
